Acitretin
Acitretin is a pharmaceutical drug with 22 clinical trials. Currently 1 active trials ongoing. Historical success rate of 86.7%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
6
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.5%
13 of 17 finished
23.5%
4 ended early
1
trials recruiting
22
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Systemic Treatment Options for Generalized Lichen Planus
Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis
Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin
Combined Effect of Acitretin and Narrow Band Ultraviolet B on Vitiligo Repigmentation
Clinical Trials (22)
Systemic Treatment Options for Generalized Lichen Planus
Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis
Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin
Combined Effect of Acitretin and Narrow Band Ultraviolet B on Vitiligo Repigmentation
Addition of Excimer Laser to Treatment With Acitretin Tablets for Psoriasis of the Palms and Soles
RA Effect on Cell Surface Molecules in Vivo
Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis
A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma
Alzheimer's Disease Acitretin Medication
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis
Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation
Acitretin and Etanercept in Psoriasis
Pilot Study on the Use of Acitretin for the Treatment of Severe Chronic Hand Dermatitis
Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)
Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis
Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2
Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer
Dose Ranging Study to Assess the Efficacy and Safety of Acitretin in Severe Plaque Type Psoriasis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 22